June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
Human IL35-producing B cells (I35Bregs) are induced by CpG DNA
Author Affiliations & Notes
  • Chengrong Yu
    Laboratory Immunology, National Eye Inst/NIH, Bethesda, Maryland, United States
  • Charles Egwuagu
    Laboratory Immunology, National Eye Inst/NIH, Bethesda, Maryland, United States
  • Footnotes
    Commercial Relationships   Chengrong Yu, None; Charles Egwuagu, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 559. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Chengrong Yu, Charles Egwuagu; Human IL35-producing B cells (I35Bregs) are induced by CpG DNA. Invest. Ophthalmol. Vis. Sci. 2017;58(8):559.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose : In the mouse, in vitro activation of B cells by LPS induces the expansion of regulatory B cells that produce IL-35 (i35-Bregs) and i35-Bregs play critical roles in suppressing ocular inflammation and amelioration of experimental autoimmune uveitis (EAU). In this study we have investigated whether TLR agonists also induce the expansion of human i35-Breg cells.

Methods : CD4+ T or CD19+ B cells were isolated from human PBMC of healthy subjects by using CD4- or CD19-magnetic bead sorting. The cells were stimulated with LPS, CD40L, CpG, PGN, anti-CD40 or anti-IgM in presence or absence of hIL-35 for 2 days. The immunophenotype was characterized by FACS using labeled mAbs specific to CD4, CD19, CD20, CD24, CD25, CD27, CD38, CD45RA, CD45RO, CD138, IgM, IgD, IL-10, IL-12p35, EBI3, IL-12Rbeta2. ELISA was used for IL-10 detection. PCR and Western blotting assays were used for cytokine detections. 3[H]-thymidine incorporation was performed with five replicate cultures.

Results : Among the TLR ligands examine (LPS, CpG, PGN), CpG was the most effective inducer of IL-10- and IL-35-producing Bregs. Similar to mouse IL-35, hIL-35 induced autocrine production of IL-35 by promoting the expansion of i35-Bregs and mediated its effects through activation of STAT1 and STAT3. We also show that human i35-Breg cells are CD27HiCD38HiCD138+ CD19+ plasmablast.

Conclusions : The expansion of human i35-Bregs by CpG and discovery that hIL-35 can induce the conversion of B-cells into IL-10- producing B cells (Bregs) or i35-Bregs allows ex-vivo production of large amounts of Bregs and i35-Bregs. These findings may also facilitate the development of adoptive Breg cell immunotherapy for autoimmune diseases.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.


This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.